A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid
Introduction: About one-third of primary biliary cholangitis (PBC) patients do not exhibit complete response to ursodeoxycholic acid (UDCA). Some of these patients were reported to benefit from the combination therapy of fibrates and UDCA, but more clinical evidence is required. In this study, we co...
Saved in:
Main Authors: | Chunlei Li (Author), Kunyu Zheng (Author), Yiran Chen (Author), Chengmei He (Author), Suying Liu (Author), Yunjiao Yang (Author), Mengtao Li (Author), Xiaofeng Zeng (Author), Li Wang (Author), Fengchun Zhang (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis
by: Zhang Y, et al.
Published: (2015) -
Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis
by: Xuan Guoyun, et al.
Published: (2022) -
Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study
by: Guilherme Grossi Lopes Cançado, et al.
Published: (2022) -
Curative effect of anti-fibrosis Chinese patent medicines combined with ursodeoxycholic acid for primary biliary cholangitis: A systematic review and meta-analysis
by: Yufei Bi, et al.
Published: (2023) -
Use of Ursodeoxycholic Acid for the Treatment of Biliary Dysfunction in Children
by: T.V. Yaroshevskaya, et al.
Published: (2013)